Respiratory manifestations are frequently overlooked as a primary presenting symptom of systemic diseases. This review explores the diverse respiratory complications associated with hematologic, endocrine and metabolic, renal, and gastrointestinal disorders. We delve into the pathophysiological mechanisms underlying these respiratory manifestations, emphasizing the importance of recognizing these connections for accurate diagnosis and optimal patient management.
The respiratory system is intricately connected to other organ systems within the human body. Consequently, various systemic diseases can manifest with significant respiratory symptoms, often complicating diagnosis and management. This review aims to provide a comprehensive overview of respiratory manifestations associated with a range of systemic disorders, highlighting their clinical significance and implications for patient care.
Anemias: Iron deficiency anemia can present with dyspnea and fatigue due to decreased oxygen-carrying capacity. Anemia of chronic disease can lead to exertional dyspnea and impaired gas exchange.
Hemoglobinopathies: Sickle cell disease can manifest with acute chest syndrome, a potentially life-threatening complication characterized by pulmonary infiltrates, fever, and respiratory distress.
Leukemias and Lymphomas: Infiltration of the lungs by leukemic cells or lymphoma can cause respiratory symptoms such as cough, dyspnea, and chest pain.
Thrombocytopenia: Can lead to spontaneous pulmonary hemorrhage.
Coagulation Disorders: Can predispose to pulmonary embolism, a life-threatening condition.
Diabetes Mellitus: Can lead to diabetic ketoacidosis, resulting in Kussmaul respirations (deep and rapid breathing). Diabetic neuropathy can affect respiratory muscles, leading to weakness and respiratory insufficiency.
Hypothyroidism: Can cause hypoventilation and respiratory muscle weakness.
Hyperthyroidism: Can lead to tachypnea, dyspnea, and atrial fibrillation with subsequent heart failure.
Obesity: Can contribute to obstructive sleep apnea and hypoventilation syndrome.
Chronic Kidney Disease: Can lead to pulmonary edema due to fluid overload and left ventricular dysfunction. Uremic toxins can also accumulate in the lungs, causing pulmonary edema and restrictive lung disease.
Acute Kidney Injury: Can result in pulmonary edema and acute respiratory distress syndrome (ARDS).
Gastroesophageal Reflux Disease (GERD): Can cause aspiration pneumonia and chronic cough.
Celiac Disease: Can present with pulmonary manifestations such as bronchiectasis and interstitial lung disease.
Liver Cirrhosis: Can lead to ascites, hepatic encephalopathy, and hepatopulmonary syndrome.
Early Recognition: Recognizing the respiratory manifestations of systemic diseases is crucial for timely diagnosis and appropriate management.
Multidisciplinary Approach: A multidisciplinary approach involving pulmonologists, hematologists, endocrinologists, nephrologists, and other specialists is essential for optimal patient care.
Thorough Investigations: A comprehensive evaluation, including history, physical examination, pulmonary function tests, imaging studies (chest X-ray, CT scan), and laboratory investigations, is crucial for accurate diagnosis.
Treatment: Treatment should focus on addressing the underlying systemic disorder while managing the respiratory complications.
Respiratory manifestations are a common feature of various systemic diseases. Recognizing these connections is crucial for accurate diagnosis and appropriate management. A multidisciplinary approach and thorough investigations are essential for optimal patient care. Further research is needed to better understand the pathophysiology of these respiratory complications and develop novel therapeutic strategies.
1.
Obesity-related cancer rising among both younger and older adults worldwide, study finds
2.
Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.
3.
Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.
4.
The way that miR-377 inhibits cells that cause prostate cancer.
5.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
1.
Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
4.
Genetic Screening: A Game Changer in Cancer Prevention
5.
Uncovering the Reality of Colon Cancer: A Look at Real Images
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
2.
Navigating the Complexities of Ph Negative ALL - Part XII
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation